Type 2 Diabetes in Children and Adolescents

Canadian Journal of Diabetes

Volumn 37, Issue SUPPL.1, 2013, Pages

  Panagiotopoulos, Constadina ^a   Riddell, Michael C ^a   Sellers, Elizabeth A C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLIMEPIRIDE; HEMOGLOBIN A1C; INFLUENZA VACCINE; INSULIN; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; ORAL ANTIDIABETIC AGENT; PNEUMOCOCCUS VACCINE; ROSIGLITAZONE;

ACANTHOSIS NIGRICANS; ADOLESCENT; ARTICLE; BARIATRIC SURGERY; BREAST FEEDING; CANADA; CHILD; CLINICAL PRACTICE; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; ENVIRONMENTAL EXPOSURE; ETHNICITY; FAMILY HISTORY; FEEDING BEHAVIOR; FOCAL GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLUENZA; INFLUENZA VACCINATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONKETOTIC DIABETIC COMA; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; RACE DIFFERENCE; RISK FACTOR; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; CANADA; CHILD; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 84876038237     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.01.043     Document Type: Article

References (67)

1. Nadeau K., Dabelea D. Epidemiology of type 2 diabetes in children and adolescents. Endocr Res 2008, 33:35-58.
2. Amed S., Dean H.J., Panagiotopoulos C., et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study. Diabetes Care 2010, 33:786-791.
3. Dabelea D., Bell R.A., D'Agostino R.B., et al. Incidence of diabetes in youth in the United States. JAMA 2007, 297:2716-2724. Writing Group for the SEARCH for Diabetes in Youth Study Group.
4. Taylor J.S., Kacmar J.E., Nothnagle M., Lawrence R.A. A systematic review of the literature associating breastfeeding with type 2 diabetes and gestational diabetes. J Am Coll Nutr 2005, 24:320-326.
5. Shields M. Measured Obesity: Overweight Canadian children and adolescents. Nutrition: Findings from the Canadian Community Health Survey 2005, Statistics Canada, Ottawa, ON, 1-34. Catalogue no. 82-620-MWE2005001.
6. Oude Luttikhuis H., Baur L., Jansen H., et al. Interventions for treating obesity in children. Cochrane Database Syst Rev 2009, (1):CD001872.
7. Canadian Society for Exercise Physiology. Canadian Physical Activity Guidelines and Canadian Sedentary Behaviour Guidelines. Available at:. Accessed February 25, 2013. http://www.csep.ca/english/view.asp?x=804.
8. Health Canada. Children-Canada's food guide. Available at:. Accessed February 25, 2013. http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/choose-choix/advice-conseil/child-enfant-eng.php.
9. Rogovik A.L., Chanoine J.P., Goldman R.D. Pharmacotherapy and weight-loss supplements for treatment of paediatric obesity. Drugs 2010, 70:335-346.
10. Freemark M. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care 2007, 30:395-402.
11. McDuffie J.R., Calis K.A., Uwaifo G.I., et al. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab 2004, 17:307-319.
12. Ozkan B., Bereket A., Turan S., Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr 2004, 163:738-741.
13. Chanoine J.P., Hampl S., Jensen C., et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005, 293:2873-2883.
14. Sellers E.A. Pharmacotherapy and bariatric surgery for the treatment of obesity in children and adolescents, 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 2007, 176:S89-S91.
15. Pinhas-Hamiel O., Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007, 369:1823-1831.
16. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128(5 pt 1):608-615.
17. Weiss R., Taksali S.E., Tamborlane W.V., et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005, 28:902-909.
18. Palmert M.R., Gordon C.M., Kartashov A.I., et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:1017-1023.
19. Dabelea D., Hanson R.L., Lindsay R.S., et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000, 49:2208-2211.
20. Young T.K., Martens P.J., Taback S.P., et al. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native Canadians. Arch Pediatr Adolesc Med 2002, 156:651-655.
21. Mendelson M., Cloutier J., Spence L., et al. Obesity and type 2 diabetes mellitus in a birth cohort of first nation children born to mothers with pediatric-onset type 2 diabetes. Pediatr Diabetes 2011, 12(3 pt 2):219-228.
22. Stoddart M.L., Blevins K.S., Lee E.T., et al. Cherokee Diabetes Study. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care 2002, 25:1009-1014.
23. Weiss R., Dziura J., Burgert T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350:2362-2374.
24. Perseghin G., Bonfanti R., Magni S., et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006, 291:E697-E703.
25. Panagiotopoulos C., Ronsley R., Davidson J. Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications. Can J Psychiatry 2009, 54:743-749.
26. Levitt Katz L.E., Swami S., Abraham M., et al. Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Pediatr Diabetes 2005, 6:84-89.
27. Libman I.M., Barinas-Mitchell E., Bartucci A., et al. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008, 93:4231-4237.
28. Sinha R., Fisch G., Teague B., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346:802-810.
29. Reinehr T., Andler W., Kapellen T., et al. Clinical characteristics of type 2 diabetes mellitus in overweight European Caucasian adolescents. Exp Clin Endocrinol Diabetes 2005, 113:167-170.
30. Pinhas-Hamiel O., Dolan L.M., Zeitler P.S. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997, 20:484-486.
31. Sellers E.A., Dean H.J. Diabetic ketoacidosis: a complication of type 2 diabetes in Canadian aboriginal youth. Diabetes Care 2000, 23:1202-1204.
32. Dabelea D., Palmer J.P., Bennett P.H., et al. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia 1999, 42:1265-1266.
33. Sellers E., Eisenbarth G., Young T.K., Dean H.J. Diabetes-associated autoantibodies in aboriginal children. Lancet 2000, 355:1156.
34. Hathout E.H., Thomas W., El-Shahawy M., et al. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001, 107:E102.
35. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998, 19:477-490.
36. Sellers E.A., Triggs-Raine B., Rockman-Greenberg C., Dean H.J. The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes. Diabetes Care 2002, 25:2202-2206.
37. Hattersley A.T. Molecular genetics goes to the diabetes clinic. Clin Med 2005, 5:476-481.
38. Pinhas-Hamiel O., Standiford D., Hamiel D., et al. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999, 153:1063-1067.
39. Johnson S.T., Newton A.S., Chopra M., et al. In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: a systematic review. BMC Pediatr 2010, 10:97.
40. Wittmeier K.D.M., Wicklow B.A., Sellers E.A.C., et al. Success with lifestyle monotherapy in youth with new-onset type 2 diabetes. Paediatr Child Health 2012, 17:129-132.
41. Wilfley D., Berkowitz R., Goebbel-Fabbri A., et al. Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the TODAY study. Diabetes Care 2011, 34:858-860. TODAY Study Group.
42. Sellers E.A., Dean H.J. Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2004, 17:1561-1564.
43. Jones K.L., Arslanian S., Peterokova V.A., et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002, 25:89-94.
44. Gottschalk M., Danne T., Vlajnic A., Cara J.F. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care 2007, 30:790-794.
45. Zeitler P., Hirst K., et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012, 366:2247-2256. TODAY Study Group.
46. Malloy J., Capparelli E., Gottschalk M., et al. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study. Clin Ther 2009, 31:806-815.
47. Inge T.H., Miyano G., Bean J., et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 2009, 123:214-222.
48. Advisory Committee on Immunization Practices Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000, 49(RR-9):1-35.
49. Crighton E.J., Elliott S.J., Moineddin R., Kanaroglou P., Upshur R. A spatial analysis of the determinants of pneumonia and influenza hospitalizations in Ontario (1992-2001). Soc Sci Med 2007, 64:1636-1650.
50. Fanella S.T., Pinto M.A., Bridger N.A., et al. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave. Infect Control Hosp Epidemiol 2011, 32:435-443.
51. Rosenbloom A.L. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr 2010, 156:180-184.
52. Fourtner S.H., Weinzimer S.A., Levitt Katz L.E. Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes. Pediatr Diabetes 2005, 6:129-135.
53. Carchman R.M., Dechert-Zeger M., Calikoglu A.S., Harris B.D. A new challenge in pediatric obesity: pediatric hyperglycemic hyperosmolar syndrome. Pediatr Crit Care Med 2005, 6:20-24.
54. Krakoff J., Lindsay R.S., Looker H.C., et al. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 2003, 26:76-81.
55. Yokoyama H., Okudaira M., Otani T., et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 1997, 20:844-847.
56. Eppens M.C., Craig M.E., Cusumano J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006, 29:1300-1306.
57. Maahs D.M., Snively B.M., Bell R.A., et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2007, 30:2593-2598.
58. Sellers E.A., Blydt-Hansen T.D., Dean H.J., et al. Macroalbuminuria and renal pathology in first nation youth with type 2 diabetes. Diabetes Care 2009, 32:786-790.
59. Sellers E.A.C., Yung G., Dean H.J. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. Pediatr Diabetes 2007, 8:384-390.
60. Kershnar A.K., Daniels S.R., Imperatore G., et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. J Pediatr 2006, 149:314-319.
61. National Cholesterol Education Program (NCEP): highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992, 89:495-501.
62. Ettinger L.M., Freeman K., DiMartino-Nardi J.R., Flynn J.T. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005, 147:67-73.
63. Norris A.W., Svoren B.M. Complications and comorbidities of type 2 diabetes. Pediatr Ann 2005, 34:710-718.
64. Nadeau K.J., Klingensmith G., Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005, 41:94-98.
65. Shield J.P., Hunt L.P., Baum J.D., et al. Screening for diabetic microalbuminuria in routine clinical care: which method?. Arch Dis Child 1995, 72:524-525.
66. Houlihan C.A., Tsalamandris C., Akdeniz A., et al. Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis 2002, 39:1183-1189.
67. Hogg R.I., Furth S., Lemley K.V., et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003, 111:1416-1421.